Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
about
Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesCross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A virusesProtective Efficacy of Cross-Reactive CD8+ T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation ThresholdCell culture-based influenza vaccines: A necessary and indispensable investment for the futureAge-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortalitySuperior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell ResponsesNS-based live attenuated H1N1 pandemic vaccines protect mice and ferretsGlycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.Immunity to seasonal and pandemic influenza A virusesAnnual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in childrenTowards universal influenza vaccines?Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly.Evasion of innate and adaptive immune responses by influenza A virus.Pathogen evolution and the immunological niche.Multiple distinct forms of CD8+ T cell cross-reactivity and specificities revealed after 2009 H1N1 influenza A virus infection in mice.Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individualsNew Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing.Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.Granzyme B ELISPOT assay to measure influenza-specific cellular immunityComparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.Correlates of vaccine protection from influenza and its complications.Influenza A virus-specific CD8 T-cell responses: from induction to function.Evolution of Influenza A Virus by Mutation and Re-Assortment.Controlling influenza by cytotoxic T-cells: calling for help from destroyers.Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections.Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?
P2860
Q27348520-7F0FE2A7-81A7-4C4F-A041-FCFF96EB2E7DQ27663289-AD63590C-FAF0-4030-BA78-3E0DB1E1EC5BQ27664060-C7F723DB-7DA0-4EA9-AFE6-EF49AFDACDB1Q28084739-F3BD154A-FEFE-457E-92E1-424C37D13E9DQ30352787-095EFDAC-B80C-4B53-84DD-9B2CD9ADF524Q30365243-20DE771B-0152-4915-9C07-A16062D2B38AQ30366119-318EF77E-F719-4ED0-93EC-06C55CD8B25BQ30384675-058855F1-AAEC-4368-9F24-A3504939D20CQ30386346-0B95BEF5-42F4-4D7A-A5F1-0F60D93964D7Q30388522-1D3EBEF0-EC3C-41D1-A64E-B0E63A1C84D3Q30394706-FD7AAC51-D5A6-4386-A8E0-18BF16E6C337Q30394731-9960D692-A0CE-407D-8BD2-9A261302C4E5Q30399357-6F057A48-4866-421E-B2FE-A76AC8DF7DD5Q30406576-442BF7B7-4B3F-4CB9-925A-72FFF56E69D3Q30406748-72457BEA-4B92-4A88-BEA1-49E8504F7797Q30414543-008A6549-A82B-42B5-A3D7-9A6706650D0EQ30414665-43C79326-D634-4DD4-AA2A-DCE3E90EDDCCQ33622358-B3C72239-C306-4077-B712-E1FE61068C3EQ33965443-2DFFE84C-8E68-40E8-9C4D-5180F1B3EB65Q34078369-D7328788-0915-4F7C-B84D-CCEA18C27041Q34430915-B1BED4CE-15E1-4CD5-B3B8-09CF5A8DA891Q35022047-58EEF17B-37AF-4734-AA58-766DCEF11075Q35078213-75054CD2-0703-40C3-8913-7ADEB7459D49Q35574887-308A8BF2-1B49-4F8C-9CAF-1F0A9F8A83E3Q36281812-AEA9FA49-DB42-489B-8948-7259520B57A8Q37341436-ABCD8E25-25B2-412A-8302-17A5A1B2C673Q37452408-CD8C5EB3-3409-4D18-A4E5-5080110381C9Q37900305-7089644A-69C9-4341-BE62-515834102108Q37976539-28C7E178-C0A5-4F3B-BE63-A1897DC1354DQ39897122-52AA6412-20C0-4023-9B7F-00FC4D4D506DQ40092344-1437BE4B-405F-4A14-8820-0997092407F7Q40730765-DEB73616-C1A4-48EA-B5D9-206EE7B61B96Q47281607-CE2012FC-9FAF-4077-9397-7001DBC15680Q50890564-37CE8DF8-860C-4B6A-935E-AF9D9C8C0685
P2860
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@ast
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@en
type
label
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@ast
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@en
prefLabel
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@ast
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@en
P50
P1433
P1476
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
@en
P2093
Joost H C M Kreijtz
P304
P356
10.1016/J.VACCINE.2009.01.016
P407
P577
2009-10-01T00:00:00Z